Overview of published, peer-reviewed EHR phenotypes derived from the CALIBER platform and the approaches of validation evidence - More information available on the CALIBER Portal https://www.caliberresearch.org/portal/phenotypes
Phenotype . | EHR data source . | Validation evidence . | |||||||
---|---|---|---|---|---|---|---|---|---|
. | Primary care . | Secondary care . | Death . | Cross-source . | Case-note review . | Prognosis . | Etiology . | Genetic . | Cross-country . |
Disease or syndrome | |||||||||
AAA | ● | ● | ● | ● | ● | ● | |||
AMI | ● | ● | ● | ● | ● | ● | ● | ● | |
AD | ● | ● | ● | ● | ● | ||||
AF | ● | ● | ● | ● | ● | ● | ● | ||
Uveitis | ● | ● | ● | ||||||
Bleeding | ● | ● | ● | ● | ● | ● | ● | ● | |
Bullous disorder | ● | ● | ● | ● | |||||
CHD | ● | ● | ● | ● | ● | ||||
Depression | ● | ● | ● | ● | |||||
Diabetes | ● | ● | ● | ● | |||||
Giant cell arteritis | ● | ● | ● | ● | |||||
HF | ● | ● | ● | ● | ● | ● | |||
HIV | ● | ● | ● | ● | ● | ||||
Hypertension | ● | ● | ● | ● | ● | ||||
HCM | ● | ● | ● | ● | |||||
Influenza | ● | ● | |||||||
MS | ● | ● | ● | ● | |||||
PAD | ● | ● | ● | ● | ● | ● | |||
Polymyalgia | ● | ● | ● | ● | |||||
PBC | ● | ● | ● | ● | |||||
Psoriasis | ● | ● | ● | ● | |||||
Dementia NOS | ● | ● | ● | ● | ● | ||||
RA | ● | ● | ● | ● | |||||
SA | ● | ● | ● | ● | ● | ||||
Intracerebral hemorrhage | ● | ● | ● | ● | ● | ● | |||
Ischemic stroke | ● | ● | ● | ● | ● | ● | |||
SAH | ● | ● | ● | ● | ● | ● | |||
Stroke NOS | ● | ● | ● | ● | ● | ● | |||
SCD | ● | ● | ● | ● | ● | ● | |||
Systemic sclerosis | ● | ● | ● | ● | |||||
TIA | ● | ● | ● | ● | ● | ● | |||
UCD | ● | ● | ● | ● | ● | ||||
UA | ● | ● | ● | ● | ● | ||||
Vascular dementia | ● | ● | ● | ● | ● | ||||
Obesity | ● | ● | ● | ● | |||||
Biomarkers | |||||||||
Blood pressure | ● | ● | |||||||
Eosinophils | ● | ● | |||||||
Heart rate | ● | ● | |||||||
Lymphocytes | ● | ● | |||||||
Neutrophils | ● | ● | |||||||
White blood cells | ● | ● | ● | ||||||
LDL cholesterol | ● | ● | |||||||
HDL cholesterol | ● | ● | |||||||
Triglycerides | ● | ● | |||||||
BMI | ● | ● | ● | ||||||
Lifestyle risk factors and other | |||||||||
Alcohol | ● | ● | |||||||
Ethnicity | ● | ● | ● | ||||||
Pregnancy | ● | ● | ● | ||||||
Sex | ● | ● | |||||||
Smoking | ● | ● | |||||||
Deprivation | ● | ● |
Phenotype . | EHR data source . | Validation evidence . | |||||||
---|---|---|---|---|---|---|---|---|---|
. | Primary care . | Secondary care . | Death . | Cross-source . | Case-note review . | Prognosis . | Etiology . | Genetic . | Cross-country . |
Disease or syndrome | |||||||||
AAA | ● | ● | ● | ● | ● | ● | |||
AMI | ● | ● | ● | ● | ● | ● | ● | ● | |
AD | ● | ● | ● | ● | ● | ||||
AF | ● | ● | ● | ● | ● | ● | ● | ||
Uveitis | ● | ● | ● | ||||||
Bleeding | ● | ● | ● | ● | ● | ● | ● | ● | |
Bullous disorder | ● | ● | ● | ● | |||||
CHD | ● | ● | ● | ● | ● | ||||
Depression | ● | ● | ● | ● | |||||
Diabetes | ● | ● | ● | ● | |||||
Giant cell arteritis | ● | ● | ● | ● | |||||
HF | ● | ● | ● | ● | ● | ● | |||
HIV | ● | ● | ● | ● | ● | ||||
Hypertension | ● | ● | ● | ● | ● | ||||
HCM | ● | ● | ● | ● | |||||
Influenza | ● | ● | |||||||
MS | ● | ● | ● | ● | |||||
PAD | ● | ● | ● | ● | ● | ● | |||
Polymyalgia | ● | ● | ● | ● | |||||
PBC | ● | ● | ● | ● | |||||
Psoriasis | ● | ● | ● | ● | |||||
Dementia NOS | ● | ● | ● | ● | ● | ||||
RA | ● | ● | ● | ● | |||||
SA | ● | ● | ● | ● | ● | ||||
Intracerebral hemorrhage | ● | ● | ● | ● | ● | ● | |||
Ischemic stroke | ● | ● | ● | ● | ● | ● | |||
SAH | ● | ● | ● | ● | ● | ● | |||
Stroke NOS | ● | ● | ● | ● | ● | ● | |||
SCD | ● | ● | ● | ● | ● | ● | |||
Systemic sclerosis | ● | ● | ● | ● | |||||
TIA | ● | ● | ● | ● | ● | ● | |||
UCD | ● | ● | ● | ● | ● | ||||
UA | ● | ● | ● | ● | ● | ||||
Vascular dementia | ● | ● | ● | ● | ● | ||||
Obesity | ● | ● | ● | ● | |||||
Biomarkers | |||||||||
Blood pressure | ● | ● | |||||||
Eosinophils | ● | ● | |||||||
Heart rate | ● | ● | |||||||
Lymphocytes | ● | ● | |||||||
Neutrophils | ● | ● | |||||||
White blood cells | ● | ● | ● | ||||||
LDL cholesterol | ● | ● | |||||||
HDL cholesterol | ● | ● | |||||||
Triglycerides | ● | ● | |||||||
BMI | ● | ● | ● | ||||||
Lifestyle risk factors and other | |||||||||
Alcohol | ● | ● | |||||||
Ethnicity | ● | ● | ● | ||||||
Pregnancy | ● | ● | ● | ||||||
Sex | ● | ● | |||||||
Smoking | ● | ● | |||||||
Deprivation | ● | ● |
AAA: abdominal aortic aneurysm; AD: Alzheimer’s disease; AF: atrial fibrillation; AMI: acute myocardial infarction; BMI: body mass index; CHD: coronary heart disease; EHR: electronic health record; HCM: hypertrophic cardiomyopathy; HDL: high-density lipoprotein; HF: heart failure; HIV: human immunodeficiency virus; LDL: low-density lipoprotein; MS: multiple sclerosis; NOS: not otherwise specified; PAD: peripheral arterial disease; PBC: primary biliary cirrhosis; RA: rheumatoid arthritis; SA: stable angina; SAH: subarachnoid hemorrhage; SCD: sudden cardiac death; TIA: transient ischemic attack; UA: unstable angina; UCD: unheralded coronary death.
Overview of published, peer-reviewed EHR phenotypes derived from the CALIBER platform and the approaches of validation evidence - More information available on the CALIBER Portal https://www.caliberresearch.org/portal/phenotypes
Phenotype . | EHR data source . | Validation evidence . | |||||||
---|---|---|---|---|---|---|---|---|---|
. | Primary care . | Secondary care . | Death . | Cross-source . | Case-note review . | Prognosis . | Etiology . | Genetic . | Cross-country . |
Disease or syndrome | |||||||||
AAA | ● | ● | ● | ● | ● | ● | |||
AMI | ● | ● | ● | ● | ● | ● | ● | ● | |
AD | ● | ● | ● | ● | ● | ||||
AF | ● | ● | ● | ● | ● | ● | ● | ||
Uveitis | ● | ● | ● | ||||||
Bleeding | ● | ● | ● | ● | ● | ● | ● | ● | |
Bullous disorder | ● | ● | ● | ● | |||||
CHD | ● | ● | ● | ● | ● | ||||
Depression | ● | ● | ● | ● | |||||
Diabetes | ● | ● | ● | ● | |||||
Giant cell arteritis | ● | ● | ● | ● | |||||
HF | ● | ● | ● | ● | ● | ● | |||
HIV | ● | ● | ● | ● | ● | ||||
Hypertension | ● | ● | ● | ● | ● | ||||
HCM | ● | ● | ● | ● | |||||
Influenza | ● | ● | |||||||
MS | ● | ● | ● | ● | |||||
PAD | ● | ● | ● | ● | ● | ● | |||
Polymyalgia | ● | ● | ● | ● | |||||
PBC | ● | ● | ● | ● | |||||
Psoriasis | ● | ● | ● | ● | |||||
Dementia NOS | ● | ● | ● | ● | ● | ||||
RA | ● | ● | ● | ● | |||||
SA | ● | ● | ● | ● | ● | ||||
Intracerebral hemorrhage | ● | ● | ● | ● | ● | ● | |||
Ischemic stroke | ● | ● | ● | ● | ● | ● | |||
SAH | ● | ● | ● | ● | ● | ● | |||
Stroke NOS | ● | ● | ● | ● | ● | ● | |||
SCD | ● | ● | ● | ● | ● | ● | |||
Systemic sclerosis | ● | ● | ● | ● | |||||
TIA | ● | ● | ● | ● | ● | ● | |||
UCD | ● | ● | ● | ● | ● | ||||
UA | ● | ● | ● | ● | ● | ||||
Vascular dementia | ● | ● | ● | ● | ● | ||||
Obesity | ● | ● | ● | ● | |||||
Biomarkers | |||||||||
Blood pressure | ● | ● | |||||||
Eosinophils | ● | ● | |||||||
Heart rate | ● | ● | |||||||
Lymphocytes | ● | ● | |||||||
Neutrophils | ● | ● | |||||||
White blood cells | ● | ● | ● | ||||||
LDL cholesterol | ● | ● | |||||||
HDL cholesterol | ● | ● | |||||||
Triglycerides | ● | ● | |||||||
BMI | ● | ● | ● | ||||||
Lifestyle risk factors and other | |||||||||
Alcohol | ● | ● | |||||||
Ethnicity | ● | ● | ● | ||||||
Pregnancy | ● | ● | ● | ||||||
Sex | ● | ● | |||||||
Smoking | ● | ● | |||||||
Deprivation | ● | ● |
Phenotype . | EHR data source . | Validation evidence . | |||||||
---|---|---|---|---|---|---|---|---|---|
. | Primary care . | Secondary care . | Death . | Cross-source . | Case-note review . | Prognosis . | Etiology . | Genetic . | Cross-country . |
Disease or syndrome | |||||||||
AAA | ● | ● | ● | ● | ● | ● | |||
AMI | ● | ● | ● | ● | ● | ● | ● | ● | |
AD | ● | ● | ● | ● | ● | ||||
AF | ● | ● | ● | ● | ● | ● | ● | ||
Uveitis | ● | ● | ● | ||||||
Bleeding | ● | ● | ● | ● | ● | ● | ● | ● | |
Bullous disorder | ● | ● | ● | ● | |||||
CHD | ● | ● | ● | ● | ● | ||||
Depression | ● | ● | ● | ● | |||||
Diabetes | ● | ● | ● | ● | |||||
Giant cell arteritis | ● | ● | ● | ● | |||||
HF | ● | ● | ● | ● | ● | ● | |||
HIV | ● | ● | ● | ● | ● | ||||
Hypertension | ● | ● | ● | ● | ● | ||||
HCM | ● | ● | ● | ● | |||||
Influenza | ● | ● | |||||||
MS | ● | ● | ● | ● | |||||
PAD | ● | ● | ● | ● | ● | ● | |||
Polymyalgia | ● | ● | ● | ● | |||||
PBC | ● | ● | ● | ● | |||||
Psoriasis | ● | ● | ● | ● | |||||
Dementia NOS | ● | ● | ● | ● | ● | ||||
RA | ● | ● | ● | ● | |||||
SA | ● | ● | ● | ● | ● | ||||
Intracerebral hemorrhage | ● | ● | ● | ● | ● | ● | |||
Ischemic stroke | ● | ● | ● | ● | ● | ● | |||
SAH | ● | ● | ● | ● | ● | ● | |||
Stroke NOS | ● | ● | ● | ● | ● | ● | |||
SCD | ● | ● | ● | ● | ● | ● | |||
Systemic sclerosis | ● | ● | ● | ● | |||||
TIA | ● | ● | ● | ● | ● | ● | |||
UCD | ● | ● | ● | ● | ● | ||||
UA | ● | ● | ● | ● | ● | ||||
Vascular dementia | ● | ● | ● | ● | ● | ||||
Obesity | ● | ● | ● | ● | |||||
Biomarkers | |||||||||
Blood pressure | ● | ● | |||||||
Eosinophils | ● | ● | |||||||
Heart rate | ● | ● | |||||||
Lymphocytes | ● | ● | |||||||
Neutrophils | ● | ● | |||||||
White blood cells | ● | ● | ● | ||||||
LDL cholesterol | ● | ● | |||||||
HDL cholesterol | ● | ● | |||||||
Triglycerides | ● | ● | |||||||
BMI | ● | ● | ● | ||||||
Lifestyle risk factors and other | |||||||||
Alcohol | ● | ● | |||||||
Ethnicity | ● | ● | ● | ||||||
Pregnancy | ● | ● | ● | ||||||
Sex | ● | ● | |||||||
Smoking | ● | ● | |||||||
Deprivation | ● | ● |
AAA: abdominal aortic aneurysm; AD: Alzheimer’s disease; AF: atrial fibrillation; AMI: acute myocardial infarction; BMI: body mass index; CHD: coronary heart disease; EHR: electronic health record; HCM: hypertrophic cardiomyopathy; HDL: high-density lipoprotein; HF: heart failure; HIV: human immunodeficiency virus; LDL: low-density lipoprotein; MS: multiple sclerosis; NOS: not otherwise specified; PAD: peripheral arterial disease; PBC: primary biliary cirrhosis; RA: rheumatoid arthritis; SA: stable angina; SAH: subarachnoid hemorrhage; SCD: sudden cardiac death; TIA: transient ischemic attack; UA: unstable angina; UCD: unheralded coronary death.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.